Objectives-Contrast-enhanced ultrasonography (CEUS) is a modern diagnostic method that can also be used to study microperfusion. This study compared the time to peak intensity measured by CEUS in patients with peripheral arterial disease (PAD) and healthy control participants.
C ontrast enhancement increases the diagnostic ability of clinical radiography, computed tomography, magnetic resonance imaging, and ultrasonography (US), and with the development of advanced scanning equipment and contrast agents, its utility is increasing. 1 Of these methods, contrast-enhanced ultrasonography (CEUS), not only can be used for perfusion in large arteries but also can be used for imaging microvascular perfusion in normal as well as pathologic states. 2 Common uses of CEUS include echocardiographic 3 assessment of hepatic and renal perfusion 4 and detection of tumor vascularity. 5 In CEUS, a contrast agent (usually a homogeneous opaque suspension containing 1-to 5-mm lipid-shelled gas microbubbles) indicates perfusion by differentiating blood circulation from surrounding tissue. Increased echogenicity of the blood facilitates estimation of the blood volume in tissue. [6] [7] [8] Contrast microbubbles are stable, and on exposure to the US beam, they reflect and resonate. The distensibility of microbubbles relative to the surrounding tissues generates a resonant vibration, which can be detected for quantifying the macrovasculature and microvasculature, even at the capillary perfusion level. [9] [10] [11] This ability makes CEUS a valuable method for dynamic assessment and quantification of the microcirculation.
Peripheral arterial disease (PAD) is an atherosclerotic condition in which chronic inflammation of arteries may result in critical limb ischemia if not properly treated. This disease is uncommon in individuals younger than 50 years, but rates rise rapidly in each decade thereafter, and by 80 years, the prevalence can be up to 20%. Thus, with increases in life expectancy, the prevalence of PAD will also increase. 12 Pertinently, the prevalence of type 2 diabetes mellitus in patients with PAD has been estimated at 50%. 13 Diagnosis of PAD involves a clinical examination, an ankle-brachial index (ABI) assessment, and a walking distance measurement before radiologic studies with computed tomography, magnetic resonance imaging, conventional angiography, or color duplex US. These techniques provide information about macrovascular changes such as stenosis and occlusion. [14] [15] [16] However, for the evaluation of microperfusion, more sophisticated methods are required, for which CEUS is potentially a valuable technique.
A number of studies have reported the outcomes of the utility of CEUS in muscle perfusion examinations of patients with PAD. In view of the variability in reported outcomes, we conducted a systematic review of relevant studies and a meta-analysis of the outcomes to generate preliminary evidence regarding the feasibility of CEUS for the diagnosis of PAD and to explore factors affecting the reported outcomes.
Materials and Methods
This study was performed by following standard guidelines for the conduction and reporting of meta-analytical reviews. 17, 18 Ethical approval and informed consent were waived because what we studied neither collected patients' information nor influenced patient care.
Eligibility Criteria
Inclusion criteria were as follows: (1) the study evaluated the utility of CEUS in patients with PAD, healthy individuals, or both; and (2) the study reported the time to peak intensity as an end point. Studies were excluded if they used CEUS for peripheral lymphadenopathy or injured muscle tissue or did not provide time to peak intensity values.
Literature Search
A comprehensive literature search was conducted in electronic databases (PubMed/MEDLINE, EMBASE, Ovid SP, Google Scholar, and ClinicalTrials.gov) to acquire the relevant research articles. Important key words and medical subject headings used were as follows: peripheral arterial disease, PAD, contrastenhanced ultrasound/ultrasonography, CEUS, anklebrachial index, ABI, time to peak intensity, TTP, maximum time to peak intensity, area under the curve (AUC), occlusion, contrast agent, leg, arm, angiopathy, atherosclerosis, thrombus, thromboembolism, diagnosis, diagnostic accuracy, receiver operating characteristic, sensitivity, specificity, and muscle reperfusion. These key terms were used in different logical combinations. The same strategy was used for each database. After initial abstract screening, eligibility criteria were devised and were followed for the selection of included studies. The search was restricted to research articles published before February 2017 in English. Additional research articles were manually searched from reference lists of relevant original studies and review articles.
Data and Analyses
Data regarding the clinical, pathologic, and demographic characteristics of the patients/participants, study end points and outcomes, and other relevant information were obtained from the identified research articles and organized in data sheets. The meta-analysis end point was the time to peak intensity in the postprovocation period. The effect sizes of the time to peak intensity reported in the individual studies were pooled under a random-effects model to achieve the overall effect as an inverse variance weighted rate. The meta-analysis was performed with Stata version 12 software (StataCorp, College Station, TX). For estimation of the significance of the difference between patients with PAD and healthy individuals, a metaanalysis of mean differences was performed with RevMan version 5.3 software (Cochrane Collaboration, London, England). Statistical heterogeneity (outcome inconsistency between the studies) was estimated by the I 2 index.
Meta-regression analyses were also performed with Stata software by using the restricted maximumlikelihood method. The dependent variable was the time to peak intensity in patients with PAD, which was tested against several explanatory variables, including the number of patients with PAD or healthy control individuals in a study, age, sex, body mass index, ABI, and walking distance.
Results
Fourteen studies [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] were found to be eligible ( Figure  1 ). In these studies, 322 patients with PAD and 314 healthy individuals underwent CEUS to study the muscle perfusion status. Important characteristics of the included studies are presented in Lipid perflutren microspheres containing octafluoropropane gas (Lantheus Medical Imaging, North Billerica, MA).
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(data from 5 studies). Important methodological characteristics of the included studies are presented in Table 2 .
In the pooled analyses, the times to peak intensity were 18 (Figure 2) . The difference between patients with PAD and healthy controls in the time to peak intensity was highly significant (mean difference, 24.80 [10.16, 39 .44] seconds; P < .00009; Figure 3) in the meta-analysis of mean differences between patients with PAD and healthy controls.
In the subgroup analyses, the time to peak intensity was approximately 6 seconds greater in participants who received the contrast agent as bolus in comparison with those who received the contrast agent as a continuous intravenous (IV) injection for patients with PAD as well as healthy controls (Figure 4) . In healthy controls, there was no meaningful difference between the time to peak intensity at rest and after exercise ( Figure 5 ).
In the meta-regression analyses, the ABI score was not significantly associated with the time to peak intensity in patients with PAD (coefficient, 212.34 [95% CI, 268.54, 43.85]; P 5 .610; I 2 5 87%). Data were insufficient for evaluation of the relationship between the walking distance and time to peak intensity in patients with PAD (5 studies). Age and sex were also not significantly associated with the time to peak intensity. 
Discussion
Results of this meta-analysis indicate that CEUS has considerable power to study PAD, as the time to peak intensity measured by CEUS was significantly greater in patients with PAD in comparison with healthy controls. However, there was no statistically significant relationship between the ABI score and the time to peak intensity in patients with PAD. Age was also not found to be related to the time to peak intensity in either patients with PAD or healthy individuals.
Several radiologic methods are available for monitoring tissue perfusion to gain information about tissue function and vitality. 33, 34 Altered muscle perfusion is an important pathophysiologic indicator of PAD, 35 as the changes in blood flow have an impact on the supply of substrates and nutrients to tissues and for the removal of harmful products, which are vital for metabolic regulation. 36 A method for the detection of changes in the muscle microcirculation can not only help in understanding the effect of muscle exercise on local perfusion but can also provide diagnostic information in pathologic conditions such as diabetic microangiopathy and PAD characterized by the different macrocirculation and microcirculation pathologic conditions. 37 Methods for the assessment of skeletal muscle perfusion, especially those involving magnetic resonance imaging, have high costs, long examination times, low availability, and utility issues. In comparison, CEUS is a promising novel method that offers several advantages, Figure 5 . Forest graph showing the time to peak intensity effect sizes of various subgroups with regard to the state at which CEUS measurements were taken. In healthy controls, there was no meaningful difference between the time to peak intensity at rest and after exercise.
including relatively low costs, availability, and sensitivity for detection of blood pool agents. It can detect and quantify real-time as well as provocation-associated local microperfusion parameters by virtue of its high spatial and temporal resolutions. 19 The utility of CEUS for assessing skeletal muscle perfusion has been reported in many conditions, including hyperinsulinemia, 38 inflammatory muscle diseases, 39 and exercise medicine. 40 In this study, meta-regression analyses did not reveal a statistically significant relationship between age and the time to peak intensity in either patients with PAD (22. 32 reported that the postocclusion maximum change in the signal intensity and the AUC during 30 seconds of reperfusion in healthy elderly individuals were less than half of those of healthy young individuals. The postprovocation perfusion AUC is thought to be an overall reflection of the skeletal muscle microcirculation. 19 In this study, data were inadequate for analyzing AUC measures.
Patients with symptomatic PAD affecting legs are initially evaluated by the ABI. An ABI of less than 0.90 indicates major disease (>50% stenosis) with sensitivity of 79% and specificity of 96%, and an ABI of less than 0.85 is found to be an independent predictor of mortality. 41 Amarteifio et al 20 reported that the time to peak intensity was significantly inversely correlated with the ABI (r 5 -0.65). In our study, although the relationship between the ABI score and the time to peak intensity was inverse in patients with PAD, it did not achieve statistical significance. Moreover, the correlation coefficient between the ABI score and age in patients with PAD in this study was r 5 -0.578 (P 5 .103). Some factors can affect this finding, however: eg, it has been reported that in patients with calcified atherosclerosis, arteries may become stiff and noncompressible; therefore, the ABI score remains ineffective (often > 1.3), making it necessary to measure the ABI at rest as well as after exercise in suspected PAD cases with a normal ABI. 41 Amarteifio et al 20 found an inverse correlation coefficient (20.38) between the time to peak intensity and walking distance in patients with PAD. In our study, no significant relationship existed between the time to peak intensity and walking distance in patients with PAD. However, this analysis was constrained by inadequate data (n 5 5 studies). In a study of 133 patients with PAD, diabetes and coronary artery disease were found to be independent predictors of walking capacity. 42 Supervised exercise programs for patients with PAD are reported to improve both the walking time and distance 43 and increase the pain-free walking distance by 180%. 44 Thus, more data will be required to identify the factors affecting CEUS-detected indices and their relationships with confounding factors.
There were some limitations to this study. First, because the use of CEUS is a recent development, little data are yet available for a comprehensive assessment of this method by a meta-analysis with regard to receiver operating characteristic parameters, the AUC for the change in blood volume over time, the contrast arrival time, the claudication time, and the peak volume of oxygen uptake/consumption in tissue. Statistical heterogeneity was also high, which indicated considerable inconsistency of outcomes among the studies. This finding could be traced back to clinical heterogeneity, as patients with different comorbid conditions were invariably included in individual studies. Methodological heterogeneity, as can be seen in Table 2 , may have also affected the outcomes. The literature search was restricted to the English language only, which may also have introduced a minor selection bias.
In conclusion, CEUS is a valuable tool for studying PAD based on its ability to differentiate between a normal (healthy individuals) and abnormal (patients with PAD) time to peak intensity, as observed in this metaanalysis. However, there was no significant relationship between the ABI score and the time to peak intensity in patients with PAD. Age and sex were not found to be related to the time to peak intensity. The use of CEUS can help in studying PAD and factors affecting the prognosis of this disease, but data are still inadequate to fully assess its diagnostic importance for PAD.
